Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection

105Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Natural killer (NK) cells and some T cells are endowed with receptors specific for class I major histocompatibility complex (MHC) molecules that can inhibit cellular effector functions. The function of the Ly49 receptor family has been studied in vitro, but no gene transfer experiments have directly established the role of these receptors in NK cell functions. We show here that transgenic expression of the H-2D(d)-specific Ly49A receptor in all NK cells and T cells conferred class I-specific inhibition of NK cell- mediated target cell lysis as well as of T cell proliferation. Furthermore, transgene expression prevented NK cell-mediated rejection of allogenic H- 2(d) bone marrow grafts by irradiated mice. These results demonstrate the function and specificity of Ly49 receptors in vivo, and establish that their subset-specific expression is necessary for the discrimination of MHC- different cells by NK cells in unmanipulated mice.

Cite

CITATION STYLE

APA

Held, W., Cado, D., & Raulet, D. H. (1996). Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. Journal of Experimental Medicine, 184(5), 2037–2041. https://doi.org/10.1084/jem.184.5.2037

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free